Pradžia › Autoimuninės ligos › Minesota
Autoimuninės ligos klinikiniai tyrimai Minesota
9 tyrimai dėl Autoimuninės ligos ieško dalyvių vietose Minesota.
Miestai Minesota
Oficialus tyrimo tekstas (anglų kalba)
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
- National Marrow Donor Program, Minneapolis
Renkami dalyviai2 fazėLaukiami sveiki savanoriai
Amžius nuo 4 iki 75 · Visoms lytims · Atnaujinta 2026-09-28 · NCT02579967RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Mayo Clinic - Accepting Adult Patients, Rochester
Renkami dalyviai2/3 fazė
Amžius nuo 6 iki 75 · Visoms lytims · Atnaujinta 2026-09-17 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
- Mayo Clinic: Division of Rheumatology, Rochester
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT07103746RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Minnesota, Minneapolis
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-08-26 · NCT06121297Abatacept for the Treatment of Giant Cell Arteritis
- Mayo Clinic, Rochester
Renkami dalyviai3 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-08-20 · NCT04474847RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Mayo Clinic Rochester, Rochester
Renkami dalyviai2/3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-17 · NCT06328777RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Mayo Clinic - Rochester, Rochester
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-08-13 · NCT06359041A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- University of Minnesota Medical School, Minneapolis
Renkami dalyviai1 fazė
Amžius nuo 12 iki 70 · Visoms lytims · Atnaujinta 2026-05-22 · NCT06308978A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- University of Minnesota Delaware Clinical Research Unit, Minneapolis
- Mayo Clinic, Rochester
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-25 · NCT06626919Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.